ORCL trades near $130, down 60 percent from its $328 high in September 2025 and off 33 percent year-to-date while the S&P 500 is up 13 percent. My conviction: Oracle stock underperforms the broad market through 2030.
The cloud giant is plowing cash into artificial intelligence infrastructure faster than it generates operating cash flow. In fiscal 2026, which ended May 31, Oracle spent $55.7 billion on capital expenditures against $32.0 billion in operating cash flow—a negative free cash flow of $23.7 billion for the year.
Quarterly capex has accelerated sharply: $8.5 billion in Q1 fiscal 2026, then $18.6 billion in Q3, then $16.5 billion in Q4, then $28.5 billion in Q1 fiscal 2027 (ended Aug. 31, 2026). That's more than triple the year-ago quarter. Management guides $90 billion to $95 billion in total capex for fiscal 2027. On a net basis, after customer prepayments, the company expects to spend roughly $70 billion this year versus $48 billion in fiscal 2026.
Customer prepayments—a key offset to capex—provided $11.4 billion in fiscal Q1 2027, boosting operating cash flow 184 percent to $23.1 billion. Yet free cash flow remained negative $5.4 billion. This marks the sixth straight quarter of negative free cash flow.
On Oracle's Sept. earnings call, CFO Hilary Maxson declined to project when the company will return to positive free cash flow. "We have not given a particular time frame on that," Maxson said. She argued that each data center project becomes "a strong free cash flow generating project once it ramps up"—but the ramp timeline is extended.
Oracle's remaining performance obligations totaled $664 billion at the end of Q1 fiscal 2027. The company will recognize only about 13 percent in the next 12 months. Roughly half won't convert into revenue until after August 2029. Yet depreciation—a cash proxy for capacity costs—jumped to $3.2 billion in Q1 from $1.4 billion a year earlier. Maxson also flagged in June that gross margin will decline this fiscal year as new data centers ramp, signaling sustained margin pressure.
To fund the gap, Oracle raised $20 billion through an at-the-market stock offering in Q1 fiscal 2027 and plans to raise $40 billion total in debt and equity. That capital raise dilutes existing shareholders and saps returns.
The structural problem: Oracle is front-loading years of capex spend to build capacity that will not generate commensurate revenue until 2029 or later. Free cash flow will remain negative or near-zero through 2028 at best. Investors betting on a near-term inflection are wrong. The risk/reward for ORCL is negative until the company demonstrates clear, sustained positive free cash flow—a milestone still two to three years away.
